Completed development of novel, frozen formulation of Bria-IMT for on-demand shipment to clinical sites New formulation to accommodate higher patient volumes at reduced per-dose costs Mechanism of action and proof of concept achieved in FDA-approved clinical trial with advanced breast cancer patients The global cancer immunotherapy market is expected to be valued at nearly $125 […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.